Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Tetrandrine Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021 4 0
Bictegravir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/18/2021 4 0
Manidipine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/01/2021 3 0
Nelfinavir mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 10 1
Daclatasvir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/18/2020 5 1
Sofosbuvir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/18/2020 6 5
Simeprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/02/2020 9 1
Excel (.xslx) CSV (.csv)